DiscoveRx adds new products and services to augment its comprehensive portfolio of the largest non-force coupled GPCR assays and reagents

Release date: 1/13/2009

Fremont, CA - January 13, 2009 - DiscoveRx continues to innovate in field of GPCR signaling assays, tools and services and now has the largest and most comprehensive portfolio of assays and reagents for non-force coupled GPCR analysis. With a portfolio of over 300 validated assays for known and orphan GPCRs along with HitHunter® second messenger and PathHunter® β-Arrestin assays and services, drug discovery researchers have expedited their GPCR drug discovery. The company expects key publications and announcements in various meetings and releases that reaffirms the value of the portfolio in GPCR drug discovery and research.

Along with ready-to-go assays, DiscoveRx also offers deorphanization, screening and profiling services for GPCR drug discovery. Now, effective January 2009, DiscoveRx is also commercializing it's HitHunter® cAMP kits to North American markets.

"There is no other company that offers such powerful suite of products and services that allow researchers to more thoroughly and easily interrogate GPCR signaling effects in whole cells without need of force coupling." said Dr. Pyare Khanna, CEO of DiscoveRx.

About DiscoveRx Corporation
Founded in 2000, DiscoveRx is a privately held, venture-backed company headquartered in Fremont, California, with an additional office in Birmingham, England. The Company pioneered the use of β-galactosidase enzyme fragment complementation in biochemical and cell based assays for discovery research, and holds extensive intellectual property in this area. DiscoveRx is dedicated to the development and commercialization of innovative solutions to study GPCRs, Kinases and other major drug target classes, and many of their innovative products have been widely adopted in pharmaceutical and biotech drug screening laboratories worldwide. The Company is also a recipient of two Frost and Sullivan 2008 awards: Award for Innovation in North American Healthcare Market as well as a European Product Line Strategy Award for it's GPCR Cell Based assay portfolio. For more information on DiscoveRx products, please visit

DiscoveRx Corporation
Sailaja Kuchibhatla
tel | 510.979.1415 x104